HER2Bi-armed activated T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HER2Bi-armed activated T cells, covering 2022-11-15 to 2022-11-15. Get the full timeline:
Most recent: Clinical Trial Update: Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer [Phase 2]